Cannabis Laws in Israel

Legal status overview

Cannabis is classified as a 'dangerous drug' under Israel's Dangerous Drugs Ordinance (New Version), 5733-1973, which criminalizes possession, cultivation, sale, and import Strong evidence^[1]. The ordinance has been amended repeatedly but remains the underlying statute.

In practice, enforcement has shifted significantly. Since April 2019, adults caught with small quantities of cannabis for personal use in a private setting generally face civil fines rather than criminal prosecution on first and second offenses — a partial decriminalization measure passed by the Knesset in 2018 Strong evidence^[2][3]. Third and subsequent offenses can still result in criminal charges, and public consumption, dealing, cultivation, and possession of larger quantities remain criminal offenses.

This article is informational only and is not legal advice. Laws change, enforcement varies, and individual circumstances matter. Consult a qualified Israeli attorney for guidance on any specific situation.

Medical cannabis program

Israel established one of the world's earliest formal medical cannabis programs. The Israeli Medical Cannabis Agency (Yakar / IMCA), within the Ministry of Health, licenses patients, physicians, cultivators, and pharmacies Strong evidence^[4].

Qualifying conditions have historically included cancer-related symptoms, chronic neuropathic pain, PTSD, Crohn's disease, multiple sclerosis, epilepsy, and selected pediatric indications, among others. Approval requires a specialist's recommendation and an IMCA license; products are dispensed through licensed pharmacies rather than dispensaries Strong evidence^[4].

A major reform begun in 2017 and rolled out over subsequent years moved the program toward a pharmacy-based, standardized-product model with GMP-grade cultivation and defined cannabinoid categories (e.g., T20/C4 labeling indicating ~20% THC, ~4% CBD) Strong evidence^[5]. The transition has been bumpy: patient groups and reporting have documented price increases and recurring shortages Strong evidence^[6].

As of 2024, Israel had tens of thousands of licensed medical cannabis patients, though exact numbers fluctuate with policy and supply Strong evidence^[5][6].

Possession, use, and penalties

Under the 2019 decriminalization framework, an adult (18+) caught using or possessing up to ~15 grams of cannabis in a private location for personal use typically receives:

• First offense: civil fine (approximately ₪1,000)
• Second offense: higher civil fine (approximately ₪2,000)
• Third offense: conditional arrangement, possibly criminal
• Fourth offense: criminal indictment possible Strong evidence^[2][3]

This framework does not apply to:

• Minors (under 18)
• Soldiers in active service (handled under military law)
• Use or possession in public spaces
• Driving under the influence
• Cultivation, even of a single plant
• Sale, distribution, or import

Israel enforces a strict prohibition on driving with any active THC in the system. Police use saliva testing, and a positive result can lead to license suspension and prosecution regardless of impairment level Strong evidence^[7]. Medical patients are not exempt from impaired driving laws.

Recreational legalization: repeatedly proposed, not enacted

Multiple Israeli governments have floated full legalization of adult-use cannabis. In 2020–2021, a government-appointed committee chaired by then–Public Security Minister Amir Ohana published a framework for a regulated recreational market, and bills advanced in the Knesset Strong evidence^[8]. The fall of the Bennett–Lapid coalition in 2022 and subsequent political instability stalled these efforts, and no legalization bill has been enacted into law as of the verification date of this article Strong evidence^[8].

The current legal posture is therefore: decriminalized personal use, regulated medical access, and continued prohibition of recreational supply.

Export, research, and industry

Israel approved medical cannabis exports in 2019 after years of internal debate; the first commercial export shipments began in 2020 Strong evidence^[9]. Israeli companies cultivate under GMP standards and have established research and supply partnerships in Europe, North America, and Australia.

Israel's research reputation is well-earned. Raphael Mechoulam and colleagues at the Hebrew University of Jerusalem isolated and characterized THC in 1964 and later contributed to the discovery of anandamide and the broader endocannabinoid system Strong evidence^[10]. Clinical research on PTSD, pediatric epilepsy, and cancer symptom management continues at Israeli universities and hospitals.

Tourists and travelers

Tourists should not assume the Israeli decriminalization framework will shield them. Bringing cannabis into Israel — even from a jurisdiction where it is legal, and even small medical amounts — is illegal and can result in detention, fines, or denied entry Strong evidence^[1]. Foreign medical cannabis prescriptions are not recognized.

If you are a patient who needs cannabis access while in Israel, the legal route is to consult an Israeli physician and apply for a domestic license, which is not realistic for short-term visitors.

Reminder: This is general information, not legal advice. Last verified June 2024. Confirm current rules with the Israeli Ministry of Health and a qualified attorney before relying on anything here.

Sources

How this page was made